The ability of cell-penetrating peptides to cross plasma membranes has been explored for various applications, including the delivery of bioactive molecules to inhibit disease-causing cellular processes. The uptake mechanisms by which cell-penetrating peptides enter cells depend on the conditions, such as the cell line the concentration and the temperature. To be used as therapeutics, each novel cell-penetrating peptide needs to be fully characterized, including their physicochemical properties, their biological activity and their uptake mechanism. Our group has developed a series of highly performing, non-toxic cell-penetrating peptides, all derived from the original sequence of transportan 10. These analogs are called PepFects and NickFec...
A major obstacle in the development of new therapeutic agents is the low bioavailability of hydrophi...
Regulation of biological processes through the use of genetic elements is a central part of biologic...
International audienceThe recent discovery of new potent therapeutic molecules that do not reach the...
The ability of cell-penetrating peptides to cross plasma membranes has been explored for various app...
The fundamental element of life known to man is the gene. The information contained in genes regulat...
The fundamental element of life known to man is the gene. The information contained in genes regulat...
Oligonucleotide-based drugs hold great promise for the treatment of many types of diseases, ranging ...
AbstractCell-penetrating peptides with the ability to escape endosomes and reach the target are of g...
The hydrophobic plasma membrane constitutes an indispensable barrier for cells in living animals. Al...
The hydrophobic plasma membrane constitutes an indispensable barrier for cells in living animals. Al...
The plasma membrane functions as a barrier, restricting entry of hydrophilic pharmaceutical agents. ...
A major obstacle for the therapeutic use of e.g. oligonucleotides is their inherently poor cellular ...
A major obstacle for the therapeutic use of e.g. oligonucleotides is their inherently poor cellular ...
A major obstacle in the development of new therapeutic agents is the low bioavailability of hydrophi...
Regulation of biological processes through the use of genetic elements is a central part of biologic...
A major obstacle in the development of new therapeutic agents is the low bioavailability of hydrophi...
Regulation of biological processes through the use of genetic elements is a central part of biologic...
International audienceThe recent discovery of new potent therapeutic molecules that do not reach the...
The ability of cell-penetrating peptides to cross plasma membranes has been explored for various app...
The fundamental element of life known to man is the gene. The information contained in genes regulat...
The fundamental element of life known to man is the gene. The information contained in genes regulat...
Oligonucleotide-based drugs hold great promise for the treatment of many types of diseases, ranging ...
AbstractCell-penetrating peptides with the ability to escape endosomes and reach the target are of g...
The hydrophobic plasma membrane constitutes an indispensable barrier for cells in living animals. Al...
The hydrophobic plasma membrane constitutes an indispensable barrier for cells in living animals. Al...
The plasma membrane functions as a barrier, restricting entry of hydrophilic pharmaceutical agents. ...
A major obstacle for the therapeutic use of e.g. oligonucleotides is their inherently poor cellular ...
A major obstacle for the therapeutic use of e.g. oligonucleotides is their inherently poor cellular ...
A major obstacle in the development of new therapeutic agents is the low bioavailability of hydrophi...
Regulation of biological processes through the use of genetic elements is a central part of biologic...
A major obstacle in the development of new therapeutic agents is the low bioavailability of hydrophi...
Regulation of biological processes through the use of genetic elements is a central part of biologic...
International audienceThe recent discovery of new potent therapeutic molecules that do not reach the...